Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001217557 | SCV001389403 | pathogenic | not provided | 2023-04-12 | criteria provided, single submitter | clinical testing | ClinVar contains an entry for this variant (Variation ID: 946651). For these reasons, this variant has been classified as Pathogenic. This premature translational stop signal has been observed in individual(s) with Usher syndrome type I (PMID: 25252889). It has also been observed to segregate with disease in related individuals. This sequence change creates a premature translational stop signal (p.Trp1466*) in the MYO7A gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in MYO7A are known to be pathogenic (PMID: 8900236, 25404053). This variant is not present in population databases (gnomAD no frequency). |
Juno Genomics, |
RCV005225319 | SCV005871603 | pathogenic | Autosomal dominant nonsyndromic hearing loss 11; Autosomal recessive nonsyndromic hearing loss 2; Usher syndrome type 1 | criteria provided, single submitter | clinical testing | PM2_Supporting+PVS1+PM3_Strong+PP1 |